regulatory
confidence high
sentiment positive
materiality 0.60
Biofrontera regains Nasdaq compliance on stockholders' equity and bid price rules
Biofrontera Inc.
- Received Nov 4 notice from Nasdaq confirming compliance with Rule 5550(b)(1) (stockholders' equity).
- Received Nov 6 notice confirming compliance with Rule 5550(a)(2) (minimum bid price ≥$1.00 for 11 consecutive days).
- Company previously disclosed deficiencies on May 21 and May 8, 2025 respectively.
- Nasdaq notes company may be subject to delisting if fails to evidence compliance upon next periodic report.